Stock screener

IONS

Conviction 4HealthcareScan · Mon, Aug 10, 2026
IONS$56.91+0.62%
ResistanceSupportVol 14Insider sell
63 bars
4
3
Vol MA14 3.12M
May 11May 28Jun 16Jul 6Jul 23Aug 10
IONIS PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.ionis.com
Price56.91
Change+0.62%
Gap-0.16%
Rel volume0.43×
Avg volume3.18M
Avg $ vol173.57M
SMA 2054.68
SMA 5066.96
SMA 20074.65
Price vs 50-15.01%
Price vs 200-23.76%
MA stackbearish
50/200 cross
Supertrenddown · 60.13
RSI (14)43
MACD hist0.98
MACD crossbull · 5d
Stoch %K / %D91 / 79
ADX (14)37
+DI / −DI22 / 34
RSI divergenceBullish
MACD divergenceBullish
ATR %+4.19%
ADR %3.63%
52w high86.50
52w low40.84
From 52w high-34.21%
Above 52w low+39.35%
New 52w highNo
SqueezeOff
Bollinger width9.25%
%B0.94
Donchian pos90.56%
Donchian high57.63
Donchian low50.01
AVWAP (52w high)70.55
vs AVWAP high-19.33%
AVWAP (52w low)70.04
vs AVWAP low-18.74%
OBV trendFlat
Chaikin MF (20)0.13
Today vs 20d0.43×
Avg vol (14d)3.12M
Avg vol (20d)3.18M
Avg $ vol (20d)173.57M
Market cap9.46B
RS 3m (vs SPY)-31.30%
RS 6m (vs SPY)-46.36%
RS line new highNo
Trend template1/8
Technical rank19.5
1 week+4.44%
1 month-2.30%
3 months-24.83%
6 months-34.21%
1 year+38.64%
YTD-28.57%
P/E-24.80
P/B21.51
P/S10.02
P/FCF-29.55
EPS-2.38
Div yield
ROE-86.73%
ROA-12.74%
Debt/Eq4.00
Current7.89
EV/EBITDA
Gross margin
Net margin-40.41%
Rev growth33.83%
EPS growth15.97%
Price target90.13
Target upside58.37%
Analyst ratingBuy
Institutional117.29%
Ent. value10.87B
Revenue267.95M
Net income-114.65M
Gross profit
Free cash flow-320.03M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out165.26M
Employees1.4K
ListedFri, May 17, 1991
Free float157.03M
Float %95.1%
Short interest20.04M
Days to cover3.7d
Short volume57.0%
Squeeze score55 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.70 vs −$1.09
Last surprise+35.8% beat
Setup gradeD
Conviction4 / 100
Pattern quality
Tech rank19.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance84.69
Support50.64
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IONS

All disclosures →
No recent disclosed trades by Congress in IONS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IONS · 5 buys · 5 sells

InsiderSideShares
HERMAN JOAN E
Director · Restricted Stock Unit · 2026-07-15
Exercise5.22K
HERMAN JOAN E
Director · Common Stock · 2026-07-15
Exercise5.22K
BERTHELSEN SPENCER R
Director · Common Stock · 2026-07-15
Exercise5.22K
BERTHELSEN SPENCER R
Director · Restricted Stock Unit · 2026-07-15
Exercise5.22K
HANTSON LUDWIG
Director · Restricted Stock Unit · 2026-07-15
Grant3.4K
Reikes Peter N
Director · Restricted Stock Unit · 2026-07-15
Grant3.4K
BENNETT C FRANK
EVP, Chief Scientific Officer · Common Stock · 2026-07-07
Sell5.54K
BENNETT C FRANK
EVP, Chief Scientific Officer · Common Stock · 2026-07-07
Acquire15K
BENNETT C FRANK
EVP, Chief Scientific Officer · Common Stock · 2026-07-07
Sell15K
BENNETT C FRANK
EVP, Chief Scientific Officer · Restricted Stock Unit · 2026-07-07
Dispose15K

SEC filings

EDGAR filings in IONS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.